{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:40:45Z","timestamp":1790293245793,"version":"4.1.0"},"reference-count":141,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T00:00:00Z","timestamp":1663459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T00:00:00Z","timestamp":1663459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s40257-022-00724-w","type":"journal-article","created":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T15:02:20Z","timestamp":1663513340000},"page":"841-852","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The Skin and Gut Microbiome in Hidradenitis Suppurativa: Current Understanding and Future Considerations for Research and Treatment"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4869-1889","authenticated-orcid":false,"given":"Marisa E.","family":"Luck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eden P.","family":"Lake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,18]]},"reference":[{"key":"724_CR1","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.jaad.2019.08.090","volume":"82","author":"SR Goldburg","year":"2020","unstructured":"Goldburg SR, Strober BE, Payette MJ. Hidradenitis suppurativa: epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol. 2020;82:1045\u201358.","journal-title":"J Am Acad Dermatol"},{"key":"724_CR2","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/jdv.14686","volume":"32","author":"E Delany","year":"2018","unstructured":"Delany E, Gormley G, Hughes R, McCarthy S, Kirthi S, Markham T, et al. A cross-sectional epidemiological study of hidradenitis suppurativa in an Irish population (SHIP). J Eur Acad Dermatol Venereol. 2018;32:467\u201373.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"724_CR3","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1001\/jama.2017.16691","volume":"318","author":"DML Saunte","year":"2017","unstructured":"Saunte DML, Jemec GBE. Hidradenitis suppurativa: advances in diagnosis and treatment. JAMA. 2017;318:2019\u201332.","journal-title":"JAMA"},{"key":"724_CR4","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.139932","volume":"5","author":"MM Lowe","year":"2020","unstructured":"Lowe MM, Naik HB, Clancy S, Pauli M, Smith KM, Bi Y, et al. Immunopathogenesis of hidradenitis suppurativa and response to anti-TNF-\u03b1 therapy. JCI insight. 2020;5: e139932.","journal-title":"JCI insight."},{"key":"724_CR5","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.jid.2018.11.018","volume":"139","author":"E Witte-H\u00e4ndel","year":"2019","unstructured":"Witte-H\u00e4ndel E, Wolk K, Tsaousi A, Irmer ML, M\u00f6\u00dfner R, Shomroni O, et al. The IL-1 pathway is hyperactive in hidradenitis suppurativa and contributes to skin infiltration and destruction. J Invest Dermatol. 2019;139:1294\u2013305.","journal-title":"J Invest Dermatol"},{"key":"724_CR6","doi-asserted-by":"crossref","unstructured":"Scheinfeld N, Sundaram M, Teixeira H, Gu Y, Okun M. Reduction in pain scores and improvement in depressive symptoms in patients with hidradenitis suppurativa treated with adalimumab in a phase 2, randomized, placebo-controlled trial. Dermatol Online J. 2016;22:13030\/qt38x5922j.","DOI":"10.5070\/D3223030360"},{"key":"724_CR7","doi-asserted-by":"publisher","first-page":"846","DOI":"10.7326\/0003-4819-157-12-201212180-00004","volume":"157","author":"AB Kimball","year":"2012","unstructured":"Kimball AB, Kerdel F, Adams D, Mrowietz U, Gelfand JM, Gniadecki R, et al. Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial. Ann Intern Med. 2012;157:846\u201355.","journal-title":"Ann Intern Med"},{"key":"724_CR8","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1111\/bjd.14338","volume":"174","author":"JL Blok","year":"2016","unstructured":"Blok JL, Li K, Brodmerkel C, Horv\u00e1tovich P, Jonkman MF, Horv\u00e1th B. Ustekinumab in hidradenitis suppurativa: Clinical results and a search for potential biomarkers in serum. Br J Dermatol. 2016;174:839\u201346.","journal-title":"Br J Dermatol"},{"key":"724_CR9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1001\/jamadermatol.2015.3903","volume":"152","author":"V Tzanetakou","year":"2016","unstructured":"Tzanetakou V, Kanni T, Giatrakou S, Katoulis A, Papadavid E, Netea MG, et al. Safety and efficacy of anakinra in severe hidradenitis suppurativa a randomized clinical trial. JAMA Dermatol. 2016;152:52\u20139.","journal-title":"JAMA Dermatol"},{"key":"724_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jaad.2019.02.068","volume":"81","author":"A Alikhan","year":"2019","unstructured":"Alikhan A, Sayed C, Alavi A, Alhusayen R, Brassard A, Burkhart C, et al. North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations. J Am Acad Dermatol. 2019;81:91\u2013101.","journal-title":"J Am Acad Dermatol"},{"key":"724_CR11","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1111\/exd.14531","volume":"31","author":"I Haferland","year":"2022","unstructured":"Haferland I, Wallenwein CM, Ickelsheimer T, Diehl S, Wacker MG, Schiffmann S, et al. Mechanism of anti-inflammatory effects of rifampicin in an ex vivo culture system of hidradenitis suppurativa. Exp Dermatol. 2022;31:1005\u201313.","journal-title":"Exp Dermatol"},{"key":"724_CR12","first-page":"15","volume":"85","author":"JQ Del Rosso","year":"2010","unstructured":"Del Rosso JQ, Schmidt NF. A review of the anti-inflammatory properties of clindamycin in the treatment of acne vulgaris. Cutis. 2010;85:15\u201324.","journal-title":"Cutis"},{"key":"724_CR13","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jaad.2016.10.042","volume":"76","author":"\u0141 Matusiak","year":"2017","unstructured":"Matusiak \u0141, Szcz\u0119ch J, Bieniek A, Nowicka-Suszko D, Szepietowski JC. Increased interleukin (IL)-17 serum levels in patients with hidradenitis suppurativa: Implications for treatment with anti-IL-17 agents. J Am Acad Dermatol. 2017;76:670\u20135.","journal-title":"J Am Acad Dermatol"},{"key":"724_CR14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00403-019-02014-8","volume":"312","author":"N Akdogan","year":"2020","unstructured":"Akdogan N, Dogan S, Incel-Uysal P, Karabulut E, Topcuoglu C, Yalcin B, et al. Serum amyloid A and C-reactive protein levels and erythrocyte sedimentation rate are important indicators in hidradenitis suppurativa. Arch Dermatol Res. 2020;312:255\u201362.","journal-title":"Arch Dermatol Res"},{"issue":"Suppl 2","key":"724_CR15","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1093\/cid\/civ137","volume":"60","author":"M-U Rashid","year":"2015","unstructured":"Rashid M-U, Zaura E, Buijs MJ, Keijser BJF, Crielaard W, Nord CE, et al. Determining the long-term effect of antibiotic administration on the human normal intestinal microbiota using culture and pyrosequencing methods. Clin Infect Dis. 2015;60(Suppl 2):S77-84.","journal-title":"Clin Infect Dis"},{"key":"724_CR16","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1126\/science.1171700","volume":"324","author":"EA Grice","year":"2009","unstructured":"Grice EA, Kong HH, Conlan S, Deming CB, Davis J, Young AC, et al. Topographical and temporal diversity of the human skin microbiome. Science (80-). 2009;324:1190\u20132.","journal-title":"Science (80-)"},{"key":"724_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.it.2004.09.014","volume":"26","author":"R Paus","year":"2005","unstructured":"Paus R, Nickoloff BJ, Ito T. A \u201chairy\u201d privilege. Trends Immunol. 2005;26:32\u201340.","journal-title":"Trends Immunol"},{"key":"724_CR18","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1172\/JCI72932","volume":"124","author":"RS Rodriguez","year":"2014","unstructured":"Rodriguez RS, Pauli ML, Neuhaus IM, Yu SS, Arron ST, Harris HW, et al. Memory regulatory T cells reside in human skin. J Clin Invest. 2014;124:1027\u201336.","journal-title":"J Clin Invest"},{"key":"724_CR19","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.chom.2017.03.001","volume":"21","author":"TC Scharschmidt","year":"2017","unstructured":"Scharschmidt TC, Vasquez KS, Pauli ML, Leitner EG, Chu K, Truong HA, et al. Commensal microbes and hair follicle morphogenesis coordinately drive treg migration into neonatal skin. Cell Host Microbe. 2017;21:467-477.e5.","journal-title":"Cell Host Microbe"},{"key":"724_CR20","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.cell.2018.12.031","volume":"176","author":"T Kobayashi","year":"2019","unstructured":"Kobayashi T, Voisin B, Kim DY, Kennedy EA, Jo JH, Shih HY, et al. Homeostatic CONTROL OF SEBACEOUS GLANDS BY INNATE LYMPHOID CELLS REGULATES COMMENSAL BACTERIA EQUILIBRIUM. Cell. 2019;176:982-997.e16.","journal-title":"Cell"},{"key":"724_CR21","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1016\/j.jid.2017.05.033","volume":"137","author":"B Moran","year":"2017","unstructured":"Moran B, Sweeney CM, Hughes R, Malara A, Kirthi S, Tobin AM, et al. Hidradenitis suppurativa is characterized by dysregulation of the Th17: Treg cell axis, which is corrected by anti-TNF therapy. J Invest Dermatol. 2017;137:2389\u201395.","journal-title":"J Invest Dermatol"},{"key":"724_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1136\/bmj.2.6181.5","volume":"2","author":"RD Leach","year":"1979","unstructured":"Leach RD, Eykyn SJ, Phillips I, Corrin B, Taylor EA. Anaerobic axillary abscess. Br Med J. 1979;2:5\u20137.","journal-title":"Br Med J"},{"key":"724_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1046\/j.1365-2133.1999.02613.x","volume":"140","author":"J Lapins","year":"1999","unstructured":"Lapins J, Jarstrand C, Emtestam L. Coagulase-negative staphylococci are the most common bacteria found in cultures from the deep portions of hidradenitis suppurativa lesions, as obtained by carbon dioxide laser surgery. Br J Dermatol. 1999;140:90\u20135.","journal-title":"Br J Dermatol"},{"key":"724_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000381959","volume":"1","author":"AC Katoulis","year":"2015","unstructured":"Katoulis AC, Koumaki D, Liakou AI, Vrioni G, Koumaki V, Kontogiorgi D, et al. Aerobic and anaerobic bacteriology of hidradenitis suppurativa: a study of 22 cases. Ski Appendage Disord. 2015;1:55\u20139.","journal-title":"Ski Appendage Disord."},{"key":"724_CR25","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1001\/jamadermatol.2017.0904","volume":"153","author":"HC Ring","year":"2017","unstructured":"Ring HC, Thorsen J, Saunte DM, Lilje B, Bay L, Riis PT, et al. The follicular skin microbiome in patients with hidradenitis suppurativa and healthy controls. JAMA Dermatol. 2017;153:897\u2013905.","journal-title":"JAMA Dermatol"},{"key":"724_CR26","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.3201\/eid2012.140064","volume":"20","author":"H Guet-Revillet","year":"2014","unstructured":"Guet-Revillet H, Coignard-Biehler H, Jais J-P, Quesne G, Frapy E, Poir\u00e9e S, et al. Bacterial pathogens associated with hidradenitis suppurativa, France. Emerg Infect Dis. 2014;20:1990\u20138.","journal-title":"Emerg Infect Dis"},{"key":"724_CR27","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1111\/jdv.15597","volume":"33","author":"HC Ring","year":"2019","unstructured":"Ring HC, Sigsgaard V, Thorsen J, Fuursted K, Fabricius S, Saunte DM, et al. The microbiome of tunnels in hidradenitis suppurativa patients. J Eur Acad Dermatol Venereol. 2019;33:1775\u201380.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"724_CR28","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/apm.12969","volume":"127","author":"HH Zhao-Fleming","year":"2019","unstructured":"Zhao-Fleming HH, Wilkinson JE, Larumbe E, Dissanaike S, Rumbaugh K. Obligate anaerobes are abundant in human necrotizing soft tissue infection samples\u2014a metagenomics analysis. APMIS. 2019;127:577\u201387.","journal-title":"APMIS"},{"key":"724_CR29","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.chom.2011.10.006","volume":"10","author":"G Hajishengallis","year":"2011","unstructured":"Hajishengallis G, Liang S, Payne MA, Hashim A, Jotwani R, Eskan MA, et al. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe. 2011;10:497\u2013506.","journal-title":"Cell Host Microbe"},{"key":"724_CR30","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/bjd.15007","volume":"176","author":"HC Ring","year":"2017","unstructured":"Ring HC, Bay L, Nilsson M, Kallenbach K, Miller IM, Saunte DM, et al. Bacterial biofilm in chronic lesions of hidradenitis suppurativa. Br J Dermatol. 2017;176:993\u20131000.","journal-title":"Br J Dermatol"},{"key":"724_CR31","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1111\/apm.12220","volume":"122","author":"AC Jahns","year":"2014","unstructured":"Jahns AC, Killasli H, Nosek D, Lundskog B, Lenngren A, Muratova Z, et al. Microbiology of hidradenitis suppurativa (acne inversa): a histological study of 27 patients. APMIS. 2014;122:804\u20139.","journal-title":"APMIS"},{"key":"724_CR32","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13756-020-00830-6","volume":"9","author":"P Bowler","year":"2020","unstructured":"Bowler P, Murphy C, Wolcott R. Biofilm exacerbates antibiotic resistance: Is this a current oversight in antimicrobial stewardship? Antimicrob Resist Infect Control. 2020;9:162.","journal-title":"Antimicrob Resist Infect Control"},{"key":"724_CR33","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/femsre\/fux010","volume":"41","author":"CW Hall","year":"2017","unstructured":"Hall CW, Mah T-F. Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria. FEMS Microbiol Rev. 2017;41:276\u2013301.","journal-title":"FEMS Microbiol Rev"},{"key":"724_CR34","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/wrr.12590","volume":"25","author":"G Schultz","year":"2017","unstructured":"Schultz G, Bjarnsholt T, James GA, Leaper DJ, McBain AJ, Malone M, et al. Consensus guidelines for the identification and treatment of biofilms in chronic nonhealing wounds. Wound Repair Regen. 2017;25:744\u201357.","journal-title":"Wound Repair Regen."},{"key":"724_CR35","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1111\/bjd.15256","volume":"176","author":"P Stoodley","year":"2017","unstructured":"Stoodley P. Evidence for a biofilm-based treatment strategy in the management of chronic hidradenitis suppurativa. Br J Dermatol. 2017;176:855\u20136.","journal-title":"Br J Dermatol"},{"key":"724_CR36","doi-asserted-by":"publisher","first-page":"e0245243","DOI":"10.1371\/journal.pone.0245243","volume":"16","author":"S Chattopadhyay","year":"2021","unstructured":"Chattopadhyay S, Arnold JD, Malayil L, Hittle L, Mongodin EF, Marathe KS, et al. Potential role of the skin and gut microbiota in premenarchal vulvar lichen sclerosus: a pilot case-control study. Mitchell C, editor. PLoS ONE. 2021;16:e0245243.","journal-title":"PLoS ONE"},{"key":"724_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/cmi.12972","volume":"21","author":"H Tada","year":"2019","unstructured":"Tada H, Nishioka T, Takase A, Numazaki K, Bando K, Matsushita K. Porphyromonas gingivalis induces the production of interleukin-31 by human mast cells, resulting in dysfunction of the gingival epithelial barrier. Cell Microbiol. 2019;21: e12972.","journal-title":"Cell Microbiol"},{"key":"724_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227006","volume":"15","author":"KR Min","year":"2020","unstructured":"Min KR, Galvis A, Baquerizo Nole KL, Sinha R, Clarke J, Kirsner RS, et al. Association between baseline abundance of Peptoniphilus, a Gram-positive anaerobic coccus, and wound healing outcomes of DFUs. PLoS ONE. 2020;15: e0227006.","journal-title":"PLoS ONE"},{"key":"724_CR39","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1365-4362.1996.tb02975.x","volume":"35","author":"I Brook","year":"1996","unstructured":"Brook I, Frazier EH, Yeager JK. Microbiology of infected atopic dermatitis. Int J Dermatol. 1996;35:791\u20133.","journal-title":"Int J Dermatol"},{"key":"724_CR40","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1099\/0022-1317-51-10-808","volume":"51","author":"I Brook","year":"2002","unstructured":"Brook I. Secondary bacterial infections complicating skin lesions. J Med Microbiol. 2002;51:808\u201312.","journal-title":"J Med Microbiol"},{"key":"724_CR41","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1046\/j.1365-2133.2000.03475.x","volume":"142","author":"I Brook","year":"2000","unstructured":"Brook I, Frazier EH, Yeager JK. Microbiology of infected poison ivy dermatitis. Br J Dermatol. 2000;142:943\u20136.","journal-title":"Br J Dermatol"},{"key":"724_CR42","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1046\/j.1365-4362.1999.00766.x","volume":"38","author":"I Brook","year":"1999","unstructured":"Brook I, Frazier EH, Yeager JK. Microbiology of infected pustular psoriasis lesions. Int J Dermatol. 1999;38:579\u201381.","journal-title":"Int J Dermatol"},{"key":"724_CR43","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.jid.2019.08.445","volume":"140","author":"HB Naik","year":"2020","unstructured":"Naik HB, Jo JH, Paul M, Kong HH. Skin microbiota perturbations are distinct and disease severity-dependent in hidradenitis suppurativa. J Invest Dermatol. 2020;140:922-925.e3.","journal-title":"J Invest Dermatol"},{"key":"724_CR44","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/j.jid.2020.02.046","volume":"140","author":"\u00c9 Riverain-Gillet","year":"2020","unstructured":"Riverain-Gillet \u00c9, Guet-Revillet H, Jais JP, Ungeheuer MN, Duchatelet S, Delage M, et al. The surface microbiome of clinically unaffected skinfolds in hidradenitis suppurativa: a cross-sectional culture-based and 16S rRNA gene amplicon sequencing study in 60 patients. J Invest Dermatol. 2020;140:1847-1855.e6.","journal-title":"J Invest Dermatol"},{"key":"724_CR45","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1177\/1203475419852049","volume":"23","author":"AH Jfri","year":"2019","unstructured":"Jfri AH, O\u2019Brien EA, Litvinov IV, Alavi A, Netchiporouk E. Hidradenitis suppurativa: comprehensive review of predisposing genetic mutations and changes. J Cutan Med Surg. 2019;23:519\u201327.","journal-title":"J Cutan Med Surg"},{"key":"724_CR46","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.jaad.2010.07.010","volume":"65","author":"C Schlapbach","year":"2011","unstructured":"Schlapbach C, H\u00e4nni T, Yawalkar N, Hunger RE. Expression of the IL-23\/Th17 pathway in lesions of hidradenitis suppurativa. J Am Acad Dermatol. 2011;65:790\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"724_CR47","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1001\/jamadermatol.2018.0141","volume":"154","author":"R Thomi","year":"2018","unstructured":"Thomi R, Cazzaniga S, Morteza Seyed Jafari S, Schlapbach C, Hunger RE. Association of hidradenitis suppurativa with T helper 1\/T helper 17 phenotypes a semantic map analysis. JAMA Dermatol. 2018;154:592\u20135.","journal-title":"JAMA Dermatol"},{"key":"724_CR48","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.jid.2019.06.151","volume":"140","author":"AM Schneider","year":"2020","unstructured":"Schneider AM, Cook LC, Zhan X, Banerjee K, Cong Z, Imamura-Kawasawa Y, et al. Loss of skin microbial diversity and alteration of bacterial metabolic function in hidradenitis suppurativa. J Invest Dermatol. 2020;140:716\u201320.","journal-title":"J Invest Dermatol"},{"key":"724_CR49","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.140598","volume":"5","author":"L Guenin-Mac\u00e9","year":"2020","unstructured":"Guenin-Mac\u00e9 L, Morel JD, Doisne JM, Schiavo A, Boulet L, Mayau V, et al. Dysregulation of tryptophan catabolism at the host-skin microbiota interface in hidradenitis suppurativa. JCI Insight. 2020;5: e140598.","journal-title":"JCI Insight."},{"key":"724_CR50","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","volume":"23","author":"A Agus","year":"2018","unstructured":"Agus A, Planchais J, Sokol H. Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe. 2018;23:716\u201324.","journal-title":"Cell Host Microbe"},{"key":"724_CR51","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.jaci.2020.01.045","volume":"146","author":"F Assan","year":"2020","unstructured":"Assan F, Gottlieb J, Tubach F, Lebbah S, Guigue N, Hickman G, et al. Anti-Saccharomyces cerevisiae IgG and IgA antibodies are associated with systemic inflammation and advanced disease in hidradenitis suppurativa. J Allergy Clin Immunol. 2020;146:452-455.e5.","journal-title":"J Allergy Clin Immunol"},{"key":"724_CR52","doi-asserted-by":"publisher","first-page":"e580","DOI":"10.1111\/jdv.18075","volume":"36","author":"HC Ring","year":"2022","unstructured":"Ring HC, Thorsen J, Fuursted K, Bjarnsholt T, Bay L, Egeberg A, et al. Amplicon sequencing demonstrates comparable follicular mycobiomes in patients with hidradenitis suppurativa compared with healthy controls. J Eur Acad Dermatology Venereol. 2022;36:e580\u20133.","journal-title":"J Eur Acad Dermatology Venereol."},{"key":"724_CR53","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.3389\/fmicb.2018.02362","volume":"9","author":"K Ogai","year":"2018","unstructured":"Ogai K, Nagase S, Mukai K, Iuchi T, Mori Y, Matsue M, et al. A comparison of techniques for collecting skin microbiome samples: swabbing versus tape-stripping. Front Microbiol. 2018;9:2362.","journal-title":"Front Microbiol"},{"key":"724_CR54","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.jid.2016.10.033","volume":"137","author":"HH Kong","year":"2017","unstructured":"Kong HH, Andersson B, Clavel T, Common JE, Jackson SA, Olson ND, et al. Performing skin microbiome research: a method to the madness. J Invest Dermatol. 2017;137:561\u20138.","journal-title":"J Invest Dermatol"},{"key":"724_CR55","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.jid.2020.03.946","volume":"140","author":"HB Naik","year":"2020","unstructured":"Naik HB, Piguet V. Standardizing hidradenitis suppurativa skin microbiome research: the methods matter. J Invest Dermatol. 2020;140:1688\u201390.","journal-title":"J Invest Dermatol"},{"key":"724_CR56","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.cell.2016.04.008","volume":"165","author":"J Oh","year":"2016","unstructured":"Oh J, Byrd AL, Park M, Kong HH, Segre JA. Temporal stability of the human skin microbiome. Cell. 2016;165:854\u201366.","journal-title":"Cell"},{"key":"724_CR57","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1126\/science.1177486","volume":"326","author":"EK Costello","year":"2009","unstructured":"Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R. Bacterial community variation in human body habitats across space and time. Science (80-). 2009;326:1694\u20137.","journal-title":"Science (80-)"},{"key":"724_CR58","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1111\/exd.14141","volume":"30","author":"SC Williams","year":"2021","unstructured":"Williams SC, Frew JW, Krueger JG. A systematic review and critical appraisal of metagenomic and culture studies in hidradenitis suppurativa. Exp Dermatol. 2021;30:1388\u201397.","journal-title":"Exp Dermatol"},{"key":"724_CR59","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/0966-842X(96)10057-3","volume":"4","author":"RD Berg","year":"1996","unstructured":"Berg RD. The indigenous gastrointestinal microflora. Trends Microbiol. 1996;4:430\u20135.","journal-title":"Trends Microbiol"},{"key":"724_CR60","doi-asserted-by":"publisher","first-page":"8787","DOI":"10.3748\/wjg.v21.i29.8787","volume":"21","author":"SM Jandhyala","year":"2015","unstructured":"Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Nageshwar RD. Role of the normal gut microbiota. World J Gastroenterol. 2015;21:8787\u2013803.","journal-title":"World J Gastroenterol"},{"key":"724_CR61","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1053\/bega.2002.0342","volume":"16","author":"F Shanahan","year":"2002","unstructured":"Shanahan F. The host-microbe interface within the gut. Best Pr Res Clin Gastroenterol. 2002;16:915\u201331.","journal-title":"Best Pr Res Clin Gastroenterol."},{"key":"724_CR62","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1210\/me.2014-1108","volume":"28","author":"G Clarke","year":"2014","unstructured":"Clarke G, Stilling RM, Kennedy PJ, Stanton C, Cryan JF, Dinan TG. Minireview: gut microbiota: the neglected endocrine organ. Mol Endocrinol. 2014;28:1221\u201338.","journal-title":"Mol Endocrinol"},{"key":"724_CR63","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1152\/physrev.1990.70.2.567","volume":"70","author":"EN Bergman","year":"1990","unstructured":"Bergman EN. Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. Physiol Rev. 1990;70:567\u201390.","journal-title":"Physiol Rev"},{"issue":"Suppl","key":"724_CR64","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.1097\/MCG.0b013e31822fecfe","volume":"45","author":"GT Macfarlane","year":"2011","unstructured":"Macfarlane GT, Macfarlane S. Fermentation in the human large intestine: its physiologic consequences and the potential contribution of prebiotics. J Clin Gastroenterol. 2011;45(Suppl):S120\u20137.","journal-title":"J Clin Gastroenterol"},{"key":"724_CR65","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3389\/fimmu.2019.00277","volume":"10","author":"D Parada Venegas","year":"2019","unstructured":"Parada Venegas D, De la Fuente MK, Landskron G, Gonz\u00e1lez MJ, Quera R, Dijkstra G, et al. Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol. 2019;10:277.","journal-title":"Front Immunol"},{"key":"724_CR66","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature18646","volume":"535","author":"HK Pedersen","year":"2016","unstructured":"Pedersen HK, Gudmundsdottir V, Nielsen HB, Hyotylainen T, Nielsen T, Jensen BA, et al. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature. 2016;535:376\u201381.","journal-title":"Nature"},{"key":"724_CR67","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.chom.2008.02.015","volume":"3","author":"PJ Turnbaugh","year":"2008","unstructured":"Turnbaugh PJ, B\u00e4ckhed F, Fulton L, Gordon JI. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe. 2008;3:213\u201323.","journal-title":"Cell Host Microbe"},{"key":"724_CR68","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature12820","volume":"505","author":"LA David","year":"2014","unstructured":"David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505:559\u201363.","journal-title":"Nature"},{"key":"724_CR69","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2147\/JIR.S292544","volume":"14","author":"M Sikora","year":"2021","unstructured":"Sikora M, Stec A, Chrabaszcz M, Giebultowicz J, Samborowska E, Jazwiec R, et al. Clinical implications of intestinal barrier damage in Psoriasis. J Inflamm Res. 2021;14:237\u201343.","journal-title":"J Inflamm Res"},{"key":"724_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.571319","volume":"11","author":"S Yegorov","year":"2020","unstructured":"Yegorov S, Babenko D, Kozhakhmetov S, Akhmaltdinova L, Kadyrova I, Nurgozhina A, et al. Psoriasis is associated with elevated gut IL-1\u03b1 and intestinal microbiome alterations. Front Immunol. 2020;11: 571319.","journal-title":"Front Immunol"},{"key":"724_CR71","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41564-018-0306-4","volume":"4","author":"EA Franzosa","year":"2019","unstructured":"Franzosa EA, Sirota-Madi A, Avila-Pacheco J, Fornelos N, Haiser HJ, Reinker S, et al. Gut microbiome structure and metabolic activity in inflammatory bowel disease. Nat Microbiol. 2019;4:293\u2013305.","journal-title":"Nat Microbiol"},{"key":"724_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.571731","volume":"11","author":"TPM Scheithauer","year":"2020","unstructured":"Scheithauer TPM, Rampanelli E, Nieuwdorp M, Vallance BA, Verchere CB, van Raalte DH, et al. Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes. Front Immunol. 2020;11:571731.","journal-title":"Front Immunol"},{"key":"724_CR73","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/nm.3914","volume":"21","author":"X Zhang","year":"2015","unstructured":"Zhang X, Zhang D, Jia H, Feng Q, Wang D, Liang D, et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med. 2015;21:895\u2013905.","journal-title":"Nat Med"},{"key":"724_CR74","doi-asserted-by":"crossref","unstructured":"Horta-Baas G, Romero-Figueroa MDS, Montiel-Jarqu\u00edn AJ, Pizano-Z\u00e1rate ML, Garc\u00eda-Mena J, Ram\u00edrez-Dur\u00e1n N. Intestinal dysbiosis and rheumatoid arthritis: a link between gut microbiota and the pathogenesis of rheumatoid arthritis. J Immunol Res. 2017;2017:4835189","DOI":"10.1155\/2017\/4835189"},{"key":"724_CR75","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/nm.4176","volume":"22","author":"KE Fujimura","year":"2016","unstructured":"Fujimura KE, Sitarik AR, Havstad S, Lin DL, Levan S, Fadrosh D, et al. Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation. Nat Med. 2016;22:1187\u201391.","journal-title":"Nat Med"},{"key":"724_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.607735","volume":"11","author":"C Shi","year":"2020","unstructured":"Shi C, Cheng M, Yang X, Lu Y, Yin H, Zeng Y, et al. Probiotic Lactobacillus rhamnosus GG promotes mouse gut microbiota diversity and T cell differentiation. Front Microbiol. 2020;11: 607735.","journal-title":"Front Microbiol"},{"key":"724_CR77","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/bjd.16734","volume":"179","author":"TH Zhu","year":"2018","unstructured":"Zhu TH, Zhu TR, Tran KA, Sivamani RK, Shi VY. Epithelial barrier dysfunctions in atopic dermatitis: a skin-gut-lung model linking microbiome alteration and immune dysregulation. Br J Dermatol. 2018;179:570\u201381.","journal-title":"Br J Dermatol"},{"key":"724_CR78","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.3390\/nu12041082","volume":"12","author":"R Chakaroun","year":"2020","unstructured":"Chakaroun R, Massier L, Kovacs P. Gut microbiome, intestinal permeability, and tissue bacteria in metabolic disease: perpetrators or bystanders? Nutrients. 2020;12:1082.","journal-title":"Nutrients"},{"key":"724_CR79","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ijwd.2019.06.026","volume":"5","author":"A Cartron","year":"2019","unstructured":"Cartron A, Driscoll MS. Comorbidities of hidradenitis suppurativa: A review of the literature. Int J women\u2019s dermatology. 2019;5:330\u20134.","journal-title":"Int J women\u2019s dermatology."},{"key":"724_CR80","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1016\/j.jid.2020.03.438","volume":"140","author":"MR Santillan","year":"2020","unstructured":"Santillan MR, Savage K, Porter M, Parker R, Simon M, Kimball AB. 430 Crohn\u2019s disease prevalence prior to and following hidradenitis suppurativa diagnosis. J Invest Dermatol. 2020;140:S56.","journal-title":"J Invest Dermatol"},{"key":"724_CR81","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jaad.2016.08.031","volume":"76","author":"IE Deckers","year":"2017","unstructured":"Deckers IE, Benhadou F, Koldijk MJ, del Marmol V, Horv\u00e1th B, Boer J, et al. Inflammatory bowel disease is associated with hidradenitis suppurativa: results from a multicenter cross-sectional study. J Am Acad Dermatol. 2017;76:49\u201353.","journal-title":"J Am Acad Dermatol"},{"key":"724_CR82","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/1346-8138.15676","volume":"48","author":"UH Jo","year":"2021","unstructured":"Jo UH, Lee JY, Lee H, Yeop KD, Kang S, Koh SJ, et al. Various skin manifestations related to inflammatory bowel disease: a nationwide cross-sectional study on the Korean population. J Dermatol. 2021;48:431\u20138.","journal-title":"J Dermatol"},{"key":"724_CR83","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12948-015-0018-8","volume":"13","author":"F Giudici","year":"2015","unstructured":"Giudici F, Maggi L, Santi R, Cosmi L, Scaletti C, Annunziato F, et al. Perianal Crohn\u2019s disease and hidradenitis suppurativa: a possible common immunological scenario. Clin Mol Allergy. 2015;13:12.","journal-title":"Clin Mol Allergy."},{"key":"724_CR84","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1111\/bjd.14075","volume":"173","author":"G Kelly","year":"2015","unstructured":"Kelly G, Hughes R, McGarry T, Van Den Born M, Adamzik K, Fitzgerald R, et al. Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa. Br J Dermatol. 2015;173:1431\u20139.","journal-title":"Br J Dermatol"},{"key":"724_CR85","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jid.2020.04.017","volume":"141","author":"S Kam","year":"2021","unstructured":"Kam S, Collard M, Lam J, Alani RM. Gut microbiome perturbations in patients with hidradenitis suppurativa: a case series. J Invest Dermatol. 2021;141:225-228.e2.","journal-title":"J Invest Dermatol"},{"key":"724_CR86","doi-asserted-by":"crossref","unstructured":"Molnar J, Mallonee CJ, Stanisic D, Homme RP, George AK, Singh M, et al. Hidradenitis suppurativa and 1-carbon metabolism: role of gut microbiome, matrix metalloproteinases, and hyperhomocysteinemia. Front Immunol. 2020;11:1730.","DOI":"10.3389\/fimmu.2020.01730"},{"key":"724_CR87","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jdermsci.2020.12.008","volume":"101","author":"SY Lam","year":"2021","unstructured":"Lam SY, Radjabzadeh D, Eppinga H, Nossent YRA, van der Zee HH, Kraaij R, et al. A microbiome study to explore the gut-skin axis in hidradenitis suppurativa. J Dermatol Sci. 2021;101:218\u201320.","journal-title":"J Dermatol Sci"},{"key":"724_CR88","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000513185","volume":"1","author":"M Sticherling","year":"2021","unstructured":"Sticherling M. Positive influence of probiotics on the gut-skin axis. Kompass Nutr Diet. 2021;1:25\u20136.","journal-title":"Kompass Nutr Diet."},{"key":"724_CR89","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1038\/s41598-018-20141-6","volume":"8","author":"OFA Larsen","year":"2018","unstructured":"Larsen OFA, Claassen E. The mechanistic link between health and gut microbiota diversity. Sci Rep. 2018;8:2183.","journal-title":"Sci Rep"},{"key":"724_CR90","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/oby.2009.167","volume":"18","author":"A Schwiertz","year":"2010","unstructured":"Schwiertz A, Taras D, Sch\u00e4fer K, Beijer S, Bos NA, Donus C, et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity. 2010;18:190\u20135.","journal-title":"Obesity"},{"key":"724_CR91","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1128\/jcm.30.7.1882-1884.1992","volume":"30","author":"EJ Baron","year":"1992","unstructured":"Baron EJ, Curren M, Henderson G, Jousimies-Somer H, Lee K, Lechowitz K, et al. Bilophila wadsworthia isolates from clinical specimens. J Clin Microbiol. 1992;30:1882\u20134.","journal-title":"J Clin Microbiol"},{"key":"724_CR92","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nature11225","volume":"487","author":"S Devkota","year":"2012","unstructured":"Devkota S, Wang Y, Musch MW, Leone V, Fehlner-Peach H, Nadimpalli A, et al. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10\u2212\/\u2212 mice. Nature. 2012;487:104\u20138.","journal-title":"Nature"},{"key":"724_CR93","doi-asserted-by":"publisher","first-page":"e1181","DOI":"10.1002\/mbo3.1181","volume":"10","author":"B Maldonado-Arriaga","year":"2021","unstructured":"Maldonado-Arriaga B, Sandoval-Jim\u00e9nez S, Rodr\u00edguez-Silverio J, Lizeth Alcar\u00e1z-Estrada S, Cort\u00e9s-Espinosa T, P\u00e9rez-Cabeza de Vaca R, et al. Gut dysbiosis and clinical phases of pancolitis in patients with ulcerative colitis. Microbiologyopen. 2021;10:e1181.","journal-title":"Microbiologyopen."},{"key":"724_CR94","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3920\/BM2016.0184","volume":"8","author":"K Lippert","year":"2017","unstructured":"Lippert K, Kedenko L, Antonielli L, Kedenko I, Gemeier C, Leitner M, et al. Gut microbiota dysbiosis associated with glucose metabolism disorders and the metabolic syndrome in older adults. Benef Microbes. 2017;8:545\u201356.","journal-title":"Benef Microbes."},{"key":"724_CR95","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/jdv.15885","volume":"34","author":"OM Moreno-Arrones","year":"2020","unstructured":"Moreno-Arrones OM, Serrano-Villar S, Perez-Brocal V, Saceda-Corralo D, Morales-Raya C, Rodrigues-Barata R, et al. Analysis of the gut microbiota in alopecia areata: identification of bacterial biomarkers. J Eur Acad Dermatology Venereol. 2020;34:400\u20135.","journal-title":"J Eur Acad Dermatology Venereol."},{"key":"724_CR96","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jid.2021.05.036","volume":"142","author":"S McCarthy","year":"2022","unstructured":"McCarthy S, Barrett M, Kirthi S, Pellanda P, Vlckova K, Tobin A-M, et al. Altered skin and gut microbiome in hidradenitis suppurativa. J Invest Dermatol. 2022;142:459-468.e15.","journal-title":"J Invest Dermatol"},{"key":"724_CR97","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/gut.2010.223263","volume":"60","author":"M Joossens","year":"2011","unstructured":"Joossens M, Huys G, Cnockaert M, De Preter V, Verbeke K, Rutgeerts P, et al. Dysbiosis of the faecal microbiota in patients with Crohn\u2019s disease and their unaffected relatives. Gut. 2011;60:631\u20137.","journal-title":"Gut"},{"key":"724_CR98","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13073-017-0490-5","volume":"9","author":"AB Hall","year":"2017","unstructured":"Hall AB, Yassour M, Sauk J, Garner A, Jiang X, Arthur T, et al. A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients. Genome Med. 2017;9:103.","journal-title":"Genome Med."},{"key":"724_CR99","doi-asserted-by":"publisher","first-page":"12672","DOI":"10.1073\/pnas.1904099116","volume":"116","author":"MT Henke","year":"2019","unstructured":"Henke MT, Kenny DJ, Cassilly CD, Vlamakis H, Xavier RJ, Clardy J. Ruminococcus gnavus, a member of the human gut microbiome associated with Crohn\u2019s disease, produces an inflammatory polysaccharide. Proc Natl Acad Sci U S A. 2019;116:12672\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"724_CR100","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/19490976.2015.1134082","volume":"7","author":"DJ Morrison","year":"2016","unstructured":"Morrison DJ, Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes. 2016;7:189\u2013200.","journal-title":"Gut Microbes."},{"key":"724_CR101","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.jid.2016.11.014","volume":"137","author":"A Schwarz","year":"2017","unstructured":"Schwarz A, Bruhs A, Schwarz T. The short-chain fatty acid sodium butyrate functions as a regulator of the skin immune system. J Invest Dermatol. 2017;137:855\u201364.","journal-title":"J Invest Dermatol"},{"key":"724_CR102","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jid.2020.04.031","volume":"141","author":"A Schwarz","year":"2021","unstructured":"Schwarz A, Philippsen R, Schwarz T. Induction of regulatory T cells and correction of cytokine disbalance by short-chain fatty acids: implications for psoriasis therapy. J Invest Dermatol. 2021;141:95-104.e2.","journal-title":"J Invest Dermatol"},{"key":"724_CR103","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/ecco-jcc\/jjw070","volume":"10","author":"H Eppinga","year":"2016","unstructured":"Eppinga H, Sperna Weiland CJ, Thio HB, van der Woude CJ, Nijsten TEC, Peppelenbosch MP, et al. Similar depletion of protective Faecalibacterium prausnitzii in psoriasis and inflammatory bowel disease, but not in hidradenitis suppurativa. J Crohn\u2019s Colitis. 2016;10:1067\u201375.","journal-title":"J Crohn\u2019s Colitis."},{"key":"724_CR104","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/ismej.2016.176","volume":"11","author":"M Lopez-Siles","year":"2017","unstructured":"Lopez-Siles M, Duncan SH, Garcia-Gil LJ, Martinez-Medina M. Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics. ISME J. 2017;11:841\u201352.","journal-title":"ISME J"},{"key":"724_CR105","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.1007\/s10620-015-3797-3","volume":"60","author":"A Wilson","year":"2015","unstructured":"Wilson A, Teft WA, Morse BL, Choi YH, Woolsey S, DeGorter MK, et al. Trimethylamine-N-oxide: a novel biomarker for the identification of inflammatory bowel disease. Dig Dis Sci. 2015;60:3620\u201330.","journal-title":"Dig Dis Sci"},{"key":"724_CR106","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s11739-020-02470-5","volume":"16","author":"L Guasti","year":"2021","unstructured":"Guasti L, Galliazzo S, Molaro M, Visconti E, Pennella B, Gaudio GV, et al. TMAO as a biomarker of cardiovascular events: a systematic review and meta-analysis. Intern Emerg Med. 2021;16:201\u20137.","journal-title":"Intern Emerg Med"},{"key":"724_CR107","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.3390\/nu10121971","volume":"10","author":"L Barrea","year":"2018","unstructured":"Barrea L, Annunziata G, Muscogiuri G, Di Somma C, Laudisio D, Maisto M, et al. Trimethylamine-N-oxide (TMAO) as novel potential biomarker of early predictors of metabolic syndrome. Nutrients. 2018;10:1971.","journal-title":"Nutrients"},{"key":"724_CR108","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.cell.2015.11.055","volume":"163","author":"Z Wang","year":"2015","unstructured":"Wang Z, Roberts AB, Buffa JA, Levison BS, Zhu W, Org E, et al. Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell. 2015;163:1585\u201395.","journal-title":"Cell"},{"key":"724_CR109","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/s41598-020-80063-0","volume":"11","author":"W Zhang","year":"2021","unstructured":"Zhang W, Miikeda A, Zuckerman J, Jia X, Charugundla S, Zhou Z, et al. Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in mice. Sci Rep. 2021;11:518.","journal-title":"Sci Rep"},{"key":"724_CR110","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.3390\/nu13061997","volume":"13","author":"L Barrea","year":"2021","unstructured":"Barrea L, Muscogiuri G, Pugliese G, de Alteriis G, Maisto M, Donnarumma M, et al. Association of trimethylamine N-oxide (TMAO) with the clinical severity of hidradenitis suppurativa (Acne Inversa). Nutrients. 2021;13:1997.","journal-title":"Nutrients"},{"key":"724_CR111","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/ced.12007","volume":"38","author":"J Roman\u00ed","year":"2013","unstructured":"Roman\u00ed J, Caix\u00e0s A, Escot\u00e9 X, Carrascosa JM, Ribera M, Rigla M, et al. Lipopolysaccharide-binding protein is increased in patients with psoriasis with metabolic syndrome, and correlates with C-reactive protein. Clin Exp Dermatol. 2013;38:81\u20134.","journal-title":"Clin Exp Dermatol"},{"key":"724_CR112","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1038\/ijo.2011.256","volume":"36","author":"JM Moreno-Navarrete","year":"2012","unstructured":"Moreno-Navarrete JM, Ortega F, Serino M, Luche E, Waget A, Pardo G, et al. Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance. Int J Obes. 2012;36:1442\u20139.","journal-title":"Int J Obes"},{"key":"724_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu13020289","volume":"13","author":"A Marti","year":"2021","unstructured":"Marti A, Mart\u00ednez I, Ojeda-rodr\u00edguez A, Azcona-sanjulian MC. Higher lipopolysaccharide binding protein and chemerin concentrations were associated with metabolic syndrome features in pediatric subjects with abdominal obesity during a lifestyle intervention. Nutrients. 2021;13:1\u201310.","journal-title":"Nutrients"},{"key":"724_CR114","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00403-019-01965-2","volume":"312","author":"P Hisp\u00e1n","year":"2020","unstructured":"Hisp\u00e1n P, Murcia O, Gonzalez-Villanueva I, Franc\u00e9s R, Gim\u00e9nez P, Riquelme J, et al. Identification of bacterial DNA in the peripheral blood of patients with active hidradenitis suppurativa. Arch Dermatol Res. 2020;312:159\u201363.","journal-title":"Arch Dermatol Res"},{"key":"724_CR115","first-page":"283","volume":"31","author":"MJA Saad","year":"2016","unstructured":"Saad MJA, Santos A, Prada PO. Linking gut microbiota and inflammation to obesity and insulin resistance. Physiology (Bethesda). 2016;31:283\u201393.","journal-title":"Physiology (Bethesda)"},{"key":"724_CR116","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1007\/s00394-021-02520-4","volume":"60","author":"Y Ghorbani","year":"2021","unstructured":"Ghorbani Y, Schwenger KJP, Allard JP. Manipulation of intestinal microbiome as potential treatment for insulin resistance and type 2 diabetes. Eur J Nutr. 2021;60:2361\u201379.","journal-title":"Eur J Nutr"},{"key":"724_CR117","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1053\/j.gastro.2012.06.031","volume":"143","author":"A Vrieze","year":"2012","unstructured":"Vrieze A, Van Nood E, Holleman F, Saloj\u00e4rvi J, Kootte RS, Bartelsman JFWM, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology. 2012;143:913-916.e7.","journal-title":"Gastroenterology"},{"key":"724_CR118","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14919","volume":"34","author":"M Iannone","year":"2021","unstructured":"Iannone M, Janowska A, Bartolomei G, Puntoni M, Oranges T, Romanelli M, et al. Systemic antibiotics in hidradenitis suppurativa: efficacy and effects of body mass index and smoking pack-year on the response to therapy. Dermatol Ther. 2021;34: e14919.","journal-title":"Dermatol Ther"},{"key":"724_CR119","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1111\/jdv.14894","volume":"32","author":"I Vilanova","year":"2018","unstructured":"Vilanova I, Hern\u00e1ndez JL, Mata C, Dur\u00e1n C, Garc\u00eda-Unzueta MT, Portilla V, et al. Insulin resistance in hidradenitis suppurativa: a case-control study. J Eur Acad Dermatol Venereol. 2018;32:820\u20134.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"724_CR120","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.abd.2020.04.009","volume":"95","author":"E \u00d6zkur","year":"2020","unstructured":"\u00d6zkur E, Erdem Y, Altunay \u0130K, Demir D, Dolu N\u00c7, Serin E, et al. Serum irisin level, insulin resistance, and lipid profiles in patients with hidradenitis suppurativa: a case-control study. An Bras Dermatol. 2020;95:708\u201313.","journal-title":"An Bras Dermatol"},{"key":"724_CR121","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1080\/09546634.2019.1592100","volume":"31","author":"L Jennings","year":"2020","unstructured":"Jennings L, Hambly R, Hughes R, Moriarty B, Kirby B. Metformin use in hidradenitis suppurativa. J Dermatol Treat. 2020;31:261\u20133.","journal-title":"J Dermatol Treat"},{"key":"724_CR122","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.36849\/JDD.2020.5447","volume":"19","author":"C Moussa","year":"2020","unstructured":"Moussa C, Wadowski L, Price H, Mirea L, O\u2019Haver J. Metformin as adjunctive therapy for pediatric patients with hidradenitis suppurativa. J Drugs Dermatol. 2020;19:1231\u20134.","journal-title":"J Drugs Dermatol"},{"key":"724_CR123","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/j.1365-2230.2008.03121.x","volume":"34","author":"B Arun","year":"2009","unstructured":"Arun B, Loffeld A. Long-standing hidradenitis suppurativa treated effectively with metformin. Clin Exp Dermatol. 2009;34:920\u20131.","journal-title":"Clin Exp Dermatol"},{"key":"724_CR124","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/nm.4345","volume":"23","author":"H Wu","year":"2017","unstructured":"Wu H, Esteve E, Tremaroli V, Khan MT, Caesar R, Manner\u00e5s-Holm L, et al. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat Med. 2017;23:850\u20138.","journal-title":"Nat Med"},{"key":"724_CR125","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/bjd.19713","volume":"185","author":"S Wright","year":"2021","unstructured":"Wright S, Strunk A, Garg A. Trends in body mass index before and after diagnosis of hidradenitis suppurativa. Br J Dermatol. 2021;185:74\u20139.","journal-title":"Br J Dermatol"},{"key":"724_CR126","doi-asserted-by":"publisher","first-page":"5222","DOI":"10.3390\/jcm10225222","volume":"10","author":"M S\u00e1nchez-D\u00edaz","year":"2021","unstructured":"S\u00e1nchez-D\u00edaz M, Salvador-Rodr\u00edguez L, Montero-V\u00edlchez T, Mart\u00ednez-L\u00f3pez A, Arias-Santiago S, Molina-Leyva A. Cumulative inflammation and HbA1c levels correlate with increased intima-media thickness in patients with severe hidradenitis suppurativa. J Clin Med. 2021;10:5222.","journal-title":"J Clin Med"},{"key":"724_CR127","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.cgh.2020.05.026","volume":"19","author":"J Fritsch","year":"2021","unstructured":"Fritsch J, Garces L, Quintero MA, Pignac-Kobinger J, Santander AM, Fern\u00e1ndez I, et al. Low-fat, high-fiber diet reduces markers of inflammation and dysbiosis and improves quality of life in patients with ulcerative colitis. Clin Gastroenterol Hepatol. 2021;19:1189-1199.e30.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"724_CR128","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1053\/j.gastro.2019.09.024","volume":"158","author":"SR Cox","year":"2020","unstructured":"Cox SR, Lindsay JO, Fromentin S, Stagg AJ, McCarthy NE, Galleron N, et al. Effects of low FODMAP diet on symptoms, fecal microbiome, and markers of inflammation in patients with quiescent inflammatory bowel disease in a randomized trial. Gastroenterology. 2020;158:176-188.e7.","journal-title":"Gastroenterology"},{"key":"724_CR129","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.jaci.2021.02.032","volume":"148","author":"S Nakamizo","year":"2021","unstructured":"Nakamizo S, Honda T, Sato T, Al Mamun M, Chow Z, Duan K, et al. High-fat diet induces a predisposition to follicular hyperkeratosis and neutrophilic folliculitis in mice. J Allergy Clin Immunol. 2021;148:473-485.e10.","journal-title":"J Allergy Clin Immunol"},{"key":"724_CR130","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14246","volume":"33","author":"JM Fernandez","year":"2020","unstructured":"Fernandez JM, Marr KD, Hendricks AJ, Price KN, Ludwig CM, Maarouf M, et al. Alleviating and exacerbating foods in hidradenitis suppurativa. Dermatol Ther. 2020;33: e14246.","journal-title":"Dermatol Ther"},{"key":"724_CR131","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/nu11010057","volume":"11","author":"L Barrea","year":"2018","unstructured":"Barrea L, Fabbrocini G, Annunziata G, Muscogiuri G, Donnarumma M, Marasca C, et al. Role of Nutrition and adherence to the Mediterranean diet in the multidisciplinary approach of hidradenitis suppurativa: evaluation of nutritional status and its association with severity of disease. Nutrients. 2018;11:57.","journal-title":"Nutrients"},{"key":"724_CR132","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1016\/j.jaad.2015.07.042","volume":"73","author":"DF William","year":"2015","unstructured":"William DF. Diet in the prevention of hidradenitis suppurativa (acne inversa). J Am Acad Dermatol. 2015;73:S52\u20134.","journal-title":"J Am Acad Dermatol"},{"key":"724_CR133","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.surg.2019.12.015","volume":"167","author":"C Aboud","year":"2020","unstructured":"Aboud C, Zamaria N, Cannistr\u00e0 C. Treatment of hidradenitis suppurativa: Surgery and yeast (Saccharomyces cerevisiae)-exclusion diet. Results after 6 years. Surgery. 2020;167:1012\u20135.","journal-title":"Surgery"},{"key":"724_CR134","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s40168-019-0709-3","volume":"7","author":"B Paetzold","year":"2019","unstructured":"Paetzold B, Willis JR, Pereira de Lima J, Kn\u00f6dlseder N, Br\u00fcggemann H, Quist SR, et al. Skin microbiome modulation induced by probiotic solutions. Microbiome. 2019;7:95.","journal-title":"Microbiome."},{"key":"724_CR135","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1034\/j.1600-0625.2003.00051.x","volume":"12","author":"L Di Marzio","year":"2003","unstructured":"Di Marzio L, Centi C, Cinque B, Masci S, Giuliani M, Arcieri A, et al. Effect of the lactic acid bacterium Streptococcus thermophilus on stratum corneum ceramide levels and signs and symptoms of atopic dermatitis patients. Exp Dermatol. 2003;12:615\u201320.","journal-title":"Exp Dermatol"},{"key":"724_CR136","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2147\/CCID.S135529","volume":"10","author":"S Blanchet-R\u00e9thor\u00e9","year":"2017","unstructured":"Blanchet-R\u00e9thor\u00e9 S, Bourd\u00e8s V, Mercenier A, Haddar CH, Verhoeven PO, Andres P. Effect of a lotion containing the heat-treated probiotic strain Lactobacillus johnsonii NCC 533 on Staphylococcus aureus colonization in atopic dermatitis. Clin Cosmet Investig Dermatol. 2017;10:249\u201357.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"724_CR137","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3389\/fmolb.2019.00092","volume":"6","author":"W-K Kim","year":"2019","unstructured":"Kim W-K, Jang YJ, Han DH, Seo B, Park S, Lee CH, et al. Administration of Lactobacillus fermentum KBL375 causes taxonomic and functional changes in gut microbiota leading to improvement of atopic dermatitis. Front Mol Biosci. 2019;6:92.","journal-title":"Front Mol Biosci"},{"key":"724_CR138","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2165\/11531420-000000000-00000","volume":"11","author":"SV Gerasimov","year":"2010","unstructured":"Gerasimov SV, Vasjuta VV, Myhovych OO, Bondarchuk LI. Probiotic supplement reduces Atopic Dermatitis in preschool children: a randomized, double-blind, placebo-controlled, clinical trial. Am J Clin Dermatol. 2010;11:351\u201361.","journal-title":"Am J Clin Dermatol"},{"key":"724_CR139","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1001\/jamadermatol.2017.3647","volume":"154","author":"V Navarro-Lopez","year":"2018","unstructured":"Navarro-Lopez V, Ramirez-Bosca A, Ramon-Vidal D, Ruzafa-Costas B, Genoves-Martinez S, Chenoll-Cuadros E, et al. Effect of oral administration of a mixture of probiotic strains on SCORAD index and use of topical steroids in young patients with moderate atopic dermatitis a randomized clinical trial. JAMA Dermatol. 2018;154:37\u201343.","journal-title":"JAMA Dermatol"},{"key":"724_CR140","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1080\/09546634.2018.1527998","volume":"30","author":"R Satta","year":"2019","unstructured":"Satta R, Pes GM, Rocchi C, Pes MC, Dore MP. Is probiotic use beneficial for skin lesions in patients with inflammatory bowel disease? J Dermatolog Treat. 2019;30:612\u20136.","journal-title":"J Dermatolog Treat"},{"key":"724_CR141","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/ced.14838","volume":"47","author":"HC Ring","year":"2022","unstructured":"Ring HC, Thorsen J, Fuursted K, Bjarnsholt T, Bay L, Saunte DM, et al. Probiotics in hidradenitis suppurativa: a potential treatment option? Clin Exp Dermatol. 2022;47:139\u201341.","journal-title":"Clin Exp Dermatol"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-022-00724-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-022-00724-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-022-00724-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T09:43:41Z","timestamp":1665999821000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-022-00724-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,18]]},"references-count":141,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["724"],"URL":"https:\/\/doi.org\/10.1007\/s40257-022-00724-w","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,18]]},"assertion":[{"value":"11 August 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There is no funding for this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Our manuscript has no associated data.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"All authors contributed to the manuscript conception and design. Material preparation, data collection and analysis were performed by all authors. The first draft of the manuscript was written by MEL, JT, and EPL and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}